A comparative study in left-sided breast cancer treated with moderate deep inspiratory breath hold versus free breathing
CONCLUSIONS: Incorporating ABC-mDIBH for left-sided breast cancer radiotherapy significantly reduces the doses received by the heart, LADA, and left and right lung, with no compromise in plan quality but with an increase in treatment time.PMID:38584227 | DOI:10.1186/s43046-024-00214-6 (Source: J Egypt Natl Canc In...)
Source: J Egypt Natl Canc In... - April 7, 2024 Category: Cancer & Oncology Authors: Anupam Muraleedharan Sandip Kumar Barik Deepak Kumar Das Saroj Kumar Das Majumdar Bikash Ranjan Mahapatra Bijay Kumar Barik Mathan Kumar Ramasubbu Nehla Haroon K M Poornima Devi U Sk Soel Ahmed Priyanka Mukherjee Ashutosh Pattanaik Avinash Badajena Minaks Source Type: research
A comparative study in left-sided breast cancer treated with moderate deep inspiratory breath hold versus free breathing
CONCLUSIONS: Incorporating ABC-mDIBH for left-sided breast cancer radiotherapy significantly reduces the doses received by the heart, LADA, and left and right lung, with no compromise in plan quality but with an increase in treatment time.PMID:38584227 | DOI:10.1186/s43046-024-00214-6 (Source: J Egypt Natl Canc In...)
Source: J Egypt Natl Canc In... - April 7, 2024 Category: Cancer & Oncology Authors: Anupam Muraleedharan Sandip Kumar Barik Deepak Kumar Das Saroj Kumar Das Majumdar Bikash Ranjan Mahapatra Bijay Kumar Barik Mathan Kumar Ramasubbu Nehla Haroon K M Poornima Devi U Sk Soel Ahmed Priyanka Mukherjee Ashutosh Pattanaik Avinash Badajena Minaks Source Type: research
A comparative study in left-sided breast cancer treated with moderate deep inspiratory breath hold versus free breathing
CONCLUSIONS: Incorporating ABC-mDIBH for left-sided breast cancer radiotherapy significantly reduces the doses received by the heart, LADA, and left and right lung, with no compromise in plan quality but with an increase in treatment time.PMID:38584227 | DOI:10.1186/s43046-024-00214-6 (Source: J Egypt Natl Canc In...)
Source: J Egypt Natl Canc In... - April 7, 2024 Category: Cancer & Oncology Authors: Anupam Muraleedharan Sandip Kumar Barik Deepak Kumar Das Saroj Kumar Das Majumdar Bikash Ranjan Mahapatra Bijay Kumar Barik Mathan Kumar Ramasubbu Nehla Haroon K M Poornima Devi U Sk Soel Ahmed Priyanka Mukherjee Ashutosh Pattanaik Avinash Badajena Minaks Source Type: research
A comparative study in left-sided breast cancer treated with moderate deep inspiratory breath hold versus free breathing
CONCLUSIONS: Incorporating ABC-mDIBH for left-sided breast cancer radiotherapy significantly reduces the doses received by the heart, LADA, and left and right lung, with no compromise in plan quality but with an increase in treatment time.PMID:38584227 | DOI:10.1186/s43046-024-00214-6 (Source: J Egypt Natl Canc In...)
Source: J Egypt Natl Canc In... - April 7, 2024 Category: Cancer & Oncology Authors: Anupam Muraleedharan Sandip Kumar Barik Deepak Kumar Das Saroj Kumar Das Majumdar Bikash Ranjan Mahapatra Bijay Kumar Barik Mathan Kumar Ramasubbu Nehla Haroon K M Poornima Devi U Sk Soel Ahmed Priyanka Mukherjee Ashutosh Pattanaik Avinash Badajena Minaks Source Type: research
A comparative study in left-sided breast cancer treated with moderate deep inspiratory breath hold versus free breathing
CONCLUSIONS: Incorporating ABC-mDIBH for left-sided breast cancer radiotherapy significantly reduces the doses received by the heart, LADA, and left and right lung, with no compromise in plan quality but with an increase in treatment time.PMID:38584227 | DOI:10.1186/s43046-024-00214-6 (Source: J Egypt Natl Canc In...)
Source: J Egypt Natl Canc In... - April 7, 2024 Category: Cancer & Oncology Authors: Anupam Muraleedharan Sandip Kumar Barik Deepak Kumar Das Saroj Kumar Das Majumdar Bikash Ranjan Mahapatra Bijay Kumar Barik Mathan Kumar Ramasubbu Nehla Haroon K M Poornima Devi U Sk Soel Ahmed Priyanka Mukherjee Ashutosh Pattanaik Avinash Badajena Minaks Source Type: research
Rechallenge of Trastuzumab-based Therapy in HER2-Positive Breast Cancer Patients who Progressed Under TDM-1
This study showed that rechallenge trastuzumab-based therapy was effective and good-tolerated in heavily pretreated patients who had progressed under TDM-1. (Source: Indian Journal of Surgical Oncology)
Source: Indian Journal of Surgical Oncology - April 1, 2024 Category: Cancer & Oncology Source Type: research
Pure mucinous adenocarcinoma of the breast with the rare lymphoplasmacytic infiltration: A case report with review of literature
We present the case of a 55-year-old female with a 15-year history of a painless, gradually enlarging palpable lump on her left breast. Upon examination, a 5 × 5 cm lump with well-defined margins and a hard consistency was found in the lower outer quadrant of the left breast. Histopathological examination confirmed a diagnosis of Mucinous Adenocarcinoma of the Left Breast. The patient underwent modified radical mastectomy and received adjuvant endocrine therapy with tamoxifen due to hormone receptor-positive status. Mucinous carcinoma of the breast is a unique entity with specific histological features including the prese...
Source: Clinical Breast Cancer - March 29, 2024 Category: Cancer & Oncology Authors: Yash Hasmukhbhai Prajapati Vishal Bhabhor Kahan Samirkumar Mehta Mithoon Barot Husen Boriwala Mohamed Omar Source Type: research
Pure mucinous adenocarcinoma of the breast with the rare lymphoplasmacytic infiltration: A case report with review of literature
We present the case of a 55-year-old female with a 15-year history of a painless, gradually enlarging palpable lump on her left breast. Upon examination, a 5 × 5 cm lump with well-defined margins and a hard consistency was found in the lower outer quadrant of the left breast. Histopathological examination confirmed a diagnosis of Mucinous Adenocarcinoma of the Left Breast. The patient underwent modified radical mastectomy and received adjuvant endocrine therapy with tamoxifen due to hormone receptor-positive status. Mucinous carcinoma of the breast is a unique entity with specific histological features including the prese...
Source: Clinical Genitourinary Cancer - March 29, 2024 Category: Cancer & Oncology Authors: Yash Hasmukhbhai Prajapati Vishal Bhabhor Kahan Samirkumar Mehta Mithoon Barot Husen Boriwala Mohamed Omar Source Type: research
Pure mucinous adenocarcinoma of the breast with the rare lymphoplasmacytic infiltration: A case report with review of literature
We present the case of a 55-year-old female with a 15-year history of a painless, gradually enlarging palpable lump on her left breast. Upon examination, a 5 × 5 cm lump with well-defined margins and a hard consistency was found in the lower outer quadrant of the left breast. Histopathological examination confirmed a diagnosis of Mucinous Adenocarcinoma of the Left Breast. The patient underwent modified radical mastectomy and received adjuvant endocrine therapy with tamoxifen due to hormone receptor-positive status. Mucinous carcinoma of the breast is a unique entity with specific histological features including the prese...
Source: Clinical Breast Cancer - March 29, 2024 Category: Cancer & Oncology Authors: Yash Hasmukhbhai Prajapati Vishal Bhabhor Kahan Samirkumar Mehta Mithoon Barot Husen Boriwala Mohamed Omar Source Type: research
Pure mucinous adenocarcinoma of the breast with the rare lymphoplasmacytic infiltration: A case report with review of literature
We present the case of a 55-year-old female with a 15-year history of a painless, gradually enlarging palpable lump on her left breast. Upon examination, a 5 × 5 cm lump with well-defined margins and a hard consistency was found in the lower outer quadrant of the left breast. Histopathological examination confirmed a diagnosis of Mucinous Adenocarcinoma of the Left Breast. The patient underwent modified radical mastectomy and received adjuvant endocrine therapy with tamoxifen due to hormone receptor-positive status. Mucinous carcinoma of the breast is a unique entity with specific histological features including the prese...
Source: Clinical Genitourinary Cancer - March 29, 2024 Category: Cancer & Oncology Authors: Yash Hasmukhbhai Prajapati Vishal Bhabhor Kahan Samirkumar Mehta Mithoon Barot Husen Boriwala Mohamed Omar Source Type: research
Pure mucinous adenocarcinoma of the breast with the rare lymphoplasmacytic infiltration: A case report with review of literature
We present the case of a 55-year-old female with a 15-year history of a painless, gradually enlarging palpable lump on her left breast. Upon examination, a 5 × 5 cm lump with well-defined margins and a hard consistency was found in the lower outer quadrant of the left breast. Histopathological examination confirmed a diagnosis of Mucinous Adenocarcinoma of the Left Breast. The patient underwent modified radical mastectomy and received adjuvant endo crine therapy with tamoxifen due to hormone receptor-positive status. Mucinous carcinoma of the breast is a unique entity with specific histological features including the...
Source: Clinical Case Reports - March 27, 2024 Category: General Medicine Authors: Yash Hasmukhbhai Prajapati,
Vishal Bhabhor,
Kahan Samirkumar Mehta,
Mithoon Barot,
Husen Boriwala,
Mohamed Omar Tags: CASE REPORT Source Type: research
Hypofractionated whole breast IMRT with HDR brachytherapy boost in early-stage breast cancer: Long-term results from a single-center
The addition of a boost to the lumpectomy bed after whole-breast (WB) radiotherapy plays a key role in the treatment of patients with breast cancer (BC). The clinical benefits of a boost with high-dose-rate brachytherapy (HDR-BT) after conventional fractionation is supported by a large body of evidence. However, few studies have described its outcomes after a hypofractionated scheme. (Source: Brachytherapy)
Source: Brachytherapy - March 23, 2024 Category: Cancer & Oncology Authors: Ana Aurora D íaz-Gavela, Elia del Cerro Peñalver, Sofía Sanchez-Garcia, Eduardo Pardo-Perez, Israel John Thuissard-Vasallo, Cristina Andreu-Vázquez, María Yolanda Molina López, Marina Pena Huertas, Luis Leonardo Guerrero-Gómez, David Sanz-Rosa, Fel Tags: Original Research Source Type: research
Cancer associated fibroblasts modulate the cytotoxicity of anti-cancer drugs in breast cancer: An in vitro study
CONCLUSIONS: The treatment of breast cancer cell lines with anti-cancer drugs in combination with secretome isolated from molecular subtype specific CAFs, reduced the cytotoxic effect of the drugs. In addition, LCMS data also highlighted different composition of secreted proteins from different breast cancer associated fibroblasts. Thus, TME has heterogenous population of CAFs across the breast cancer subtypes and in vitro experiments highlight their contribution to chemotherapy resistance which needs further validation.PMID:38517765 | DOI:10.3233/BD-230011 (Source: Breast Disease)
Source: Breast Disease - March 22, 2024 Category: Cancer & Oncology Authors: Dharambir Kashyap Shalmoli Bhattacharya Santosh Irinike Siddhant Khare Ashim Das Gurpreet Singh Amanjit Bal Source Type: research
